Masthead Google Plus Twitter YouTube Facebook On-line Bill Pay

Custom Search
ADVERTISEMENT
Gas Buddy
Ag Info
Today's Health Headlines
WASHINGTON (Reuters) - Prospects for U.S. House passage of a healthcare system overhaul before President Donald Trump's 100th day in office dimmed on Thursday as Republicans struggled to find the needed votes, lawmakers and aides said.

(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Bayer AG's drug Stivarga to treat liver cancer, the first such approval in nearly a decade.

SEOUL (Reuters) - South Korea said on Thursday it has fined Swiss drugmaker Novartis 55.1 billion won ($48.80 million) for offering doctors kickbacks to recommend the company's drugs, and also suspended insurance coverage for some of its drugs.

(Reuters Health) - Despite increased attention to deaths and injuries resulting from clashes with police, U.S. emergency department visits for police-associated injuries have remained stable at about 51,000 a year since 2006, researchers say.

Reuters Health) - Exposing babies to puppies and other furry pets might help them accumulate two types of bacteria in their gut that are associated with a lower risk of allergies and obesity, a Canadian study suggests.

(Reuters Health) - For young women running on little sleep, 10 minutes of stair walking increased energy more than the amount of caffeine in a soda or half a cup of coffee, according to a small study.

(Reuters Health) - College is increasingly a gateway for young adults in the U.S. to begin using marijuana and the risk keeps growing the more “normalized” pot use becomes, researchers say.

(Reuters) - Biomarin Pharmaceuticals Inc said the annual price for its drug, which won U.S. approval on Thursday, to treat a rare and fatal type of pediatric brain disease is expected to be $486,000 after mandatory government discounts and rebates.

(Reuters Health) - Older adults who want to get moving to help boost their brain function have a wide variety of workouts to choose from, a research review suggests.

ZURICH (Reuters) - Swiss drugmaker Roche, encouraged by better than expected first-quarter sales, said it was confident new drugs will help to deliver revenue and profit growth even as its older medicines take a hit from cheaper copies.

ENTERTAINMENT NEWS
NEW YORK (Reuters) - Emma Watson says making her new movie "The Circle," about a fictitious social m...
(Reuters) - Fox News faces renewed legal claims that it mistreated non-white employees, a week after...
NEW YORK (Reuters) - Jonathan Demme, the eclectic movie director whose work ranged from thrillers li...
SPORTS NEWS
BERLIN (Reuters) - Former world number one Maria Sharapova eased past fellow Russian Ekaterina Makar...
(Reuters) - Canadian Eugenie Bouchard has lashed out at the WTA for giving Maria Sharapova the chanc...
BARCELONA, (Reuters) - Third seed Rafael Nadal remained on course for a 10th Barcelona Open title af...
Login to access your Mark Twain Web Mail
Username: 
Password:
Don't have a Mark Twain email? Click Here!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
loading
FINANCE NEWS
(Reuters) - Goldman Sachs Group Inc plans to promote its high-interest bearing deposit products in ...
NEW YORK (Reuters) - Investors ramped up their exposure to U.S.-based international-focused stock fu...
CHICAGO (Reuters) - Good things come to those who wait, the old saying goes. And more Americans are ...